posted on 2022-03-22, 11:03authored byEthan Hills, Tyler J. Woodward, Stanley Fields, Benjamin M. Brandsen
Antibiotic resistance is a growing threat to public health, making
the development of antibiotics of critical importance. One promising
class of potential new antibiotics are ribosomally synthesized and
post-translationally modified peptides (RiPPs), which include klebsidin,
a lasso peptide from Klebsiella pneumoniae that inhibits certain bacterial RNA polymerases. We develop a high-throughput
assay based on growth inhibition of Escherichia coli to analyze the mutational tolerance of klebsidin. We transform a
library of klebsidin variants into E. coli and use next-generation DNA sequencing to count the frequency of
each variant before and after its expression, thereby generating functional
scores for 320 of 361 single amino acid changes. We identify multiple
positions in the macrocyclic ring and the C-terminal tail region of
klebsidin that are intolerant to mutation, as well as positions in
the loop region that are highly tolerant to mutation. Characterization
of selected peptide variants scored as active reveals that each adopts
a threaded lasso conformation; active loop variants applied extracellularly
as peptides slow the growth of E. coli and K. pneumoniae. We generate an E. coli strain with a mutation in RNA polymerase
that confers resistance to klebsidin and similarly carry out a selection
with the klebsidin library. We identify a single variant, klebsidin
F9Y, that maintains activity against the resistant E. coli when expressed intracellularly. This finding
supports the utility of this method and suggests that comprehensive
mutational analysis of lasso peptides can identify unique and potentially
improved variants.